Rafferty Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Sell |
|
|||||
|
2025
Q1 | $2.54M | Sell |
|
|||||
|
2024
Q4 | $2.44M | Sell |
|
|||||
|
2024
Q3 | $2.44M | Sell |
|
|||||
|
2024
Q2 | $2.87M | Sell |
|
|||||
|
2024
Q1 | $7.76M | Buy |
|
|||||
|
2023
Q4 | $5.92M | Sell |
|
|||||
|
2023
Q3 | $5.97M | Sell |
|
|||||
|
2023
Q2 | $9.61M | Buy |
|
|||||
|
2023
Q1 | $7.7M | Sell |
|
|||||
|
2022
Q4 | $9.16M | Buy |
|
|||||
|
2022
Q3 | $5.19M | Buy |
|
|||||
|
2022
Q2 | $1.3M | Sell |
|
|||||
|
2022
Q1 | $1.92M | Buy |
|
|||||
|
2021
Q4 | $1.55M | Buy |
|
|||||
|
2021
Q3 | $1.02M | Buy |
|
|||||
|
2021
Q2 | $1.1M | Sell |
|
|||||
|
2021
Q1 | $2.01M | Buy |
|
|||||
|
2020
Q4 | $202K | Sell |
|
|||||
|
2020
Q3 | $693K | Buy |
|
|||||
|
2020
Q2 | $392K | Buy |
|
|||||
|
2020
Q1 | $131K | Sell |
|
|||||
|
2019
Q4 | $1.36M | Buy |
|
|||||
|
2019
Q3 | $900K | Buy |
|